HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Posttransplant adoptive immunotherapy with interleukin-2 in children suffering from neuroectodermal tumors with poor prognosis.

AuthorsK Kałwak, M Ussowicz, E Gorczyńska, J Toporski, D Turkiewicz, J Bogusławska-Jaworska, A Chybicka
JournalTransplantation proceedings (Transplant Proc) Vol. 34 Issue 2 Pg. 665-7 (Mar 2002) ISSN: 0041-1345 [Print] United States
PMID12009658 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Interleukin-2
  • Busulfan
  • Melphalan
Topics
  • Adolescent
  • Bone Marrow Transplantation (immunology)
  • Busulfan (therapeutic use)
  • Child
  • Child, Preschool
  • Cytotoxicity, Immunologic
  • Gene Amplification
  • Genes, myc
  • Humans
  • Immunotherapy, Adoptive
  • Interleukin-2 (therapeutic use)
  • Killer Cells, Natural (immunology)
  • Melphalan (therapeutic use)
  • Neuroectodermal Tumors (therapy)
  • Platelet Count
  • Prognosis
  • Sequence Deletion
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: